Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruth Bender Atik

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Health Technology Assessment (Winchester, England)|November 25, 2021
Mifepristone and misoprostol versus placebo and misoprostol for resolution of miscarriage in women diagnosed with missed miscarriage: the MifeMiso RCTAdam Devall, Justin Chu, Leanne Beeson, et al.
Health Technology Assessment (Winchester, England)|May 27, 2016
PROMISE: first-trimester progesterone therapy in women with a history of unexplained recurrent miscarriages - a randomised, double-blind, placebo-controlled, international multicentre trial and economic evaluationArri Coomarasamy, Helen Williams, Ewa Truchanowicz, et al.
Lancet (London, England)|August 28, 2020
Mifepristone and misoprostol versus misoprostol alone for the management of missed miscarriage (MifeMiso): a randomised, double-blind, placebo-controlled trialJustin J Chu, Adam J Devall, Leanne E Beeson, et al.
The New England Journal of Medicine|May 9, 2019
A Randomized Trial of Progesterone in Women with Bleeding in Early PregnancyArri Coomarasamy, Adam J Devall, Versha Cheed, et al.
Health Technology Assessment (Winchester, England)|July 2, 2020
Progesterone to prevent miscarriage in women with early pregnancy bleeding: the PRISM RCTArri Coomarasamy, Hoda M Harb, Adam J Devall, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Health Technology Assessment (Winchester, England)|November 25, 2021
Mifepristone and misoprostol versus placebo and misoprostol for resolution of miscarriage in women diagnosed with missed miscarriage: the MifeMiso RCTAdam Devall, Justin Chu, Leanne Beeson, et al.
Health Technology Assessment (Winchester, England)|May 27, 2016
PROMISE: first-trimester progesterone therapy in women with a history of unexplained recurrent miscarriages - a randomised, double-blind, placebo-controlled, international multicentre trial and economic evaluationArri Coomarasamy, Helen Williams, Ewa Truchanowicz, et al.
Lancet (London, England)|August 28, 2020
Mifepristone and misoprostol versus misoprostol alone for the management of missed miscarriage (MifeMiso): a randomised, double-blind, placebo-controlled trialJustin J Chu, Adam J Devall, Leanne E Beeson, et al.
The New England Journal of Medicine|May 9, 2019
A Randomized Trial of Progesterone in Women with Bleeding in Early PregnancyArri Coomarasamy, Adam J Devall, Versha Cheed, et al.
Health Technology Assessment (Winchester, England)|July 2, 2020
Progesterone to prevent miscarriage in women with early pregnancy bleeding: the PRISM RCTArri Coomarasamy, Hoda M Harb, Adam J Devall, et al.
Pageof 2